NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
81 hedge funds and large institutions have $126M invested in Navidea Biopharmaceuticals Inc. in 2015 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
98% less call options, than puts
Call options by funds: $332K | Put options by funds: $14M
Holders
81
Holding in Top 10
1
Calls
$332K
Puts
$14M
Top Buyers
| 1 | +$1.85M | |
| 2 | +$1.63M | |
| 3 | +$1.4M | |
| 4 |
PM
Platinum Management
New York
|
+$1.17M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.05M |
Top Sellers
| 1 | -$789K | |
| 2 | -$742K | |
| 3 | -$549K | |
| 4 |
Bank of New York Mellon
New York
|
-$281K |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$108K |